RGNT
Regentis Biomaterials Ltd.
Set alert
1.37 USD +0.01 +0.74%
1.31 Day range 1.42
1.23 52-week range 9.40
- YTD
- -79.67%
- 1 year
- -81.73%
- Open
- 1.42
- Prev close
- 1.36
- Mkt cap
- 9.62M
- Vol
- 24.87K
- Avg vol
- 51.58K
- EPS
- -2.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.31
- High
- 1.42
Financials — quick view
RGNT Revenue — quarterly 16.78M
RGNT Net income — quarterly -2.24M
RGNT EPS — quarterly -0.55
News
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
- Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
- 12 Health Care Stocks Moving In Monday's Intraday Session
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
- Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
- Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Regentis Gets Japan Patent Office Notice of Allowance For Organic Solvent‑Free Protein‑Polymer Conjugate Compositions, Covering GelrinC Manufacturing Process And Ready‑to‑Use Liquid Formulation for Articular Cartilage Repair
Your note
Sign in to keep a note on RGNT — it syncs with the Stock Master app.